Experimental and investigational drugs for the treatment of acute otitis media
Authors:
- 10 July 2019
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 28 (8) , 687-694
Abstract
Introduction: Acute otitis media (AOM) is a common disease, particularly in infants and young children. Almost all children experience at least one episode of AOM in the first 3 years of age, and approximately 50% experience recurrent episodes in the same period of time. Areas covered: Some new potentially effective preventive or therapeutic approaches to AOM have been identified and are not discussed even in the most updated guidelines. The main aim of this narrative review is to detail what has been recently suggested. Expert opinion: Several new measures have been suggested to reduce systemic antibiotic abuse in AOM therapy and prophylaxis. For therapy, the administration of preparations containing antibiotics, bacteriophages or peptides can allow trans-tympanic passage of effective anti-otopathogen measures and the use of vaccines or immunoglobulins can disrupt biofilm. For AOM prophylaxis, new vaccines and the use of probiotics by nasal spray are in development. However, further advances in the selection of children for whom antimicrobial therapy and/or prophylaxis measures are truly needed could be derived from studies that analyse the association between genetic characteristics of the host and development of AOM with specific characteristics of aetiology or tendency to recur.Keywords
Funding Information
- the Italian Ministry of Health (Bando Giovani Ricercatori 2009 GR-2009-1596786)
This publication has 73 references indexed in Scilit:
- The Diagnosis and Management of Acute Otitis MediaPediatrics, 2013
- Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis mediaInternational Journal of General Medicine, 2012
- Bacteriocin-producing oral streptococci and inhibition of respiratory pathogensFEMS Immunology & Medical Microbiology, 2012
- Regulation of Virulence Gene Expression Resulting from Streptococcus pneumoniae and Nontypeable Haemophilus influenzae Interactions in Chronic DiseasePLOS ONE, 2011
- Serotype replacement in disease after pneumococcal vaccinationThe Lancet, 2011
- Poor adherence to antibiotic prescribing guidelines in acute otitis media—obstacles, implications, and possible solutionsEuropean Journal of Pediatrics, 2010
- The biofilm matrixNature Reviews Microbiology, 2010
- Variations in Amoxicillin Pharmacokinetic/Pharmacodynamic Parameters May Explain Treatment Failures in Acute Otitis MediaPediatric Drugs, 2009
- Has UK guidance affected general practitioner antibiotic prescribing for otitis media in children?Journal of Public Health, 2008
- The PilA protein of non‐typeable Haemophilus influenzae plays a role in biofilm formation, adherence to epithelial cells and colonization of the mammalian upper respiratory tractMolecular Microbiology, 2007